Jill Marinis

Jill Marinis, Ph.D., R.D., is currently the Executive Director, Global Product Leader (GPL) at CSL Behring. They have previously served as a Senior Director and Compound Development Team Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2019 to 2022, and held roles at GlaxoSmithKline, including Investigator in ImmunoInflammation and Early Development Leader. Jill completed their Ph.D. in Pathology/Immunology at Case Western Reserve University, where they focused on innate immune signaling. Their early career included working as a Clinical Dietitian at Santa Barbara Cottage Hospital after completing a dietetic internship.